LIN|Analyst Targets
LIN|Company Info
LIN|Insider Trading
LIN|Fundamentals
LIN|Earnings Snapshot
EPS
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $4.52 | - | - |
| Q2'26 | $4.53 | $4.50 | -0.6% |
| Q1'26 | $4.45 | $4.33 | -2.6% |
| Q4'25 | $4.22 | $4.20 | -0.4% |
| Q3'25 | $4.18 | $4.21 | +0.7% |
| Q2'25 | $4.04 | $4.09 | +1.4% |
Revenue
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q3'26 | $9.2B | - | - |
| Q2'26 | $9.1B | $9.3B | +2.3% |
| Q1'26 | $8.9B | $8.8B | -1.6% |
| Q4'25 | $8.7B | $8.8B | +0.4% |
| Q3'25 | - | $8.6B | - |
| Q2'25 | - | $8.5B | - |
LIN|Monthly Returns
Market Data
LIN Stock Snapshot
- Market cap
- 226.85B
- P/E ratio
- 31.3
- Day range
- $492.44 – $495.00
- News sentiment
- 59/100 · Neutral
- Analyst target
- $544.30 (+10.4%)
- Consensus
- Buy · 32 analysts
LIN is in a holding pattern - neither trend nor momentum has taken control. At this size, moves are driven by index flows and macro positioning as much as by company news.
Reverse DCF
What growth is priced into LIN?
At today's price, Linde plc needs to grow free cash flow about 25.0% a year for the next 10 years to justify its valuation at a 7.80% cost of capital. Over its actual history it has compounded free cash flow at 18.6% a year, so the market is asking for 6.3 percentage points above its own delivered rate. On that basis LIN looks priced above what its own growth record supports.
- Implied FCF growth
- 25.0%
- Historical FCF CAGR
- 18.6%
- Growth gap
- +6.3 pts
- Verdict
- RICH
- Discount rate (WACC)
- 7.80%
- Beta
- 0.63
Behaviour On Record
What LIN's own history says about today's numbers
- Realized volatility (21d)
- 14.5% 22nd pct
- Below its peak
- -10.0%
- vs 200-day average
- +0.8%
- Up days (1y)
- 50%
Linde plc is currently running 14.5% annualised volatility over the last 21 sessions. Measured against LIN's own 8 years of daily returns rather than a market-wide average, that is the 22nd percentile — unusually subdued by its own history, against a typical reading of 19.3%. The distinction matters because a number that looks calm for one stock is turbulent for another, and the absolute figure on its own tells you neither.
LIN is trading -10.0% below its running peak. Across 7 full years on file, its median worst-drawdown-in-a-year was -14.3%, and the deepest was -32.9% in 2020. The current pullback is therefore shallower than what this stock gives back in a typical year, which is context worth having before treating it as a dislocation.
Price sits +0.8% from its 200-day moving average. Against every other day in its history, that gap ranks at the 23rd percentile — a narrower gap than it typically runs. Over the past year LIN closed higher on 50% of sessions, and it is currently 3 sessions into a rising streak.
On October specifically: over 7 years of records, LIN finished the month higher 4 of 7 times, with a median return of +3.2% and an average of +0.5%. Its strongest month historically has been November at +4.4% on average, its weakest September at -2.5%. Seasonality is a weak signal on its own — a decade is a small sample and regimes change — but it is a real distribution rather than a rule of thumb.
Overnight risk is measurable too: LIN has opened more than 2% away from the prior close in 67 of 1,996 sessions (3.4% of the time), with the largest gaps running +7.5% and -13.8%. For anyone holding through an event, that rate is a better guide to overnight exposure than the intraday range.
Across the last 3 dated reports on file, LIN moved an average of 2.4% in the session after earnings, closing higher 0 of those 3 times, with a median move of -3.5% and a largest of -3.6%.
All figures computed from 1,997 daily closes between 2018-10-31 and 2026-10-13, split-adjusted, recomputed daily. Percentiles are against LIN's own 8-year history, not a peer group or index.
Sector Rotation
Is money rotating into or out of LIN's sector?
Linde plc sits in the Materials sector, currently ranked 10th of 12 GICS sectors by relative-strength rotation score (improving).
- Sector rank
- #10 of 12
- Sector state
- Improving
- Sector rotation score
- 18
Analyst Rating Changes
Are analysts turning bullish or bearish on LIN?
Barclays most recently initiated coverage on Linde plc to Overweight on Oct 13, 2026 with a price target of $577. Over the last 90 days, coverage has run 0 upgrades against 0 downgrades, a net mixed lean.
- Latest action
- Barclays — Overweight
- 90-day upgrades
- 0
- 90-day downgrades
- 0
- Net rating momentum
- 0
Peers & ETF holders
LIN peers & ETF holders
Specialty ChemicalsMarket cap · today
News Sentiment Analysis
Sentiment gathered from recent headlines
Recent News Coverage
Most recent articles, ranked by recency (click to expand).
Technical Analysis
Real-time indicators across multiple timeframes
| Manager | Trend | Shares Held | % of Co. | Position Value | Filed |
|---|---|---|---|---|---|
| Schonfeld Strategic Advisors LLC | ▼ Sell | 42,458 | 0.01% | $22.03M | 2026-08-14 |
| Ancora Advisors LLC | ▼ Sell | 39,414 | 0.01% | $20.45M | 2026-08-14 |
| Winton Group Ltd | ▲ Buy | 7,720 | 0.00% | $4.01M | 2026-08-07 |
| Brevan Howard Capital Management LP | ▼ Sell | 6,432 | 0.00% | $3.34M | 2026-08-14 |
| Graham Capital Management, L.P. | ▼ Sold out | 0 | 0.00% | $0 | 2026-08-14 |
| Member | Chamber | State | Type | Amount | Traded | Filed |
|---|---|---|---|---|---|---|
| Kevin Hern | House | OK01 | ▼ Sell | $15K - $50K | 2026-09-02 | 2026-09-25 |
| Kevin Hern | House | OK01 | ▼ Sell | $15K - $50K | 2026-08-31 | 2026-09-25 |
| Thomas H. Kean | House | NJ07 | ▲ Buy | $1K - $15K | 2026-08-10 | 2026-09-12 |
| Alan Armstrong | Senate | OK | ▼ Sell | $15K - $50K | 2026-03-27 | 2026-07-21 |
| Thomas H. Kean | House | NJ07 | ▲ Buy | $1K - $15K | 2026-03-26 | 2026-04-13 |
| Thomas H. Kean | House | NJ07 | ▲ Buy | $1K - $15K | 2026-02-18 | 2026-03-18 |
| Gilbert Cisneros | House | CA31 | ▲ Buy | $1K - $15K | 2026-01-09 | 2026-02-13 |
| Gilbert Cisneros | House | CA31 | ▲ Buy | $1K - $15K | 2025-12-19 | 2026-01-12 |
| Valerie Hoyle | House | OR04 | ▼ Sell | $1K - $15K | 2025-09-23 | 2025-10-10 |
| Lisa McClain | House | MI09 | ▼ Sell | $1K - $15K | 2025-07-16 | 2025-08-13 |
| Lisa McClain | House | MI09 | ▲ Buy | $1K - $15K | 2025-06-24 | 2025-08-13 |
| Jefferson Shreve | House | IN06 | ▼ Sell | $50K - $100K | 2025-05-12 | 2025-06-22 |
| Jonathan Jackson | House | IL01 | ▼ Sell | $50K - $100K | 2025-05-07 | 2025-06-13 |
| Dan Newhouse | House | WA04 | ▼ Sell | $1K - $15K | 2025-04-11 | 2025-05-16 |
| Rob Bresnahan | House | PA08 | ▼ Sell | $1K - $15K | 2025-04-08 | 2025-05-08 |
| Jared Moskowitz | House | FL23 | ▲ Buy | $1K - $15K | 2025-04-07 | 2025-05-09 |
| Jefferson Shreve | House | IN06 | ▲ Buy | $50K - $100K | 2025-04-07 | 2025-05-08 |
| George Whitesides | House | CA27 | ▼ Sell | $100K - $250K | 2025-03-24 | 2025-04-23 |
| Rob Bresnahan | House | PA08 | ▼ Sell | $1K - $15K | 2025-02-25 | 2025-03-27 |
| Jefferson Shreve | House | IN06 | ▼ Sell | $15K - $50K | 2025-02-24 | 2025-03-09 |
| Rob Bresnahan | House | PA08 | ▼ Sell | $1K - $15K | 2025-01-13 | 2025-02-13 |
| Valerie Hoyle | House | OR04 | ▲ Buy | $1K - $15K | 2024-10-29 | 2025-09-12 |
| Shelley Moore Capito | Senate | WV | ▼ Sell | $1K - $15K | 2022-10-17 | 2022-11-13 |
| Susan M. Collins | Senate | ME | ▲ Buy | $15K - $50K | 2022-01-06 | 2022-02-17 |
| Susan M. Collins | Senate | ME | ▼ Sell | $15K - $50K | 2018-12-21 | 2019-01-08 |